Human coronaviruses: What do they cause?

Antiviral Therapy

Volumn 12, Issue 4 B, 2007, Pages 651-658

  Van Der Hoek, Lia ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZAURIDINE; BETA DEXTRO N 4 HYDROXYCYTIDINE; IMMUNOGLOBULIN; RIBAVIRIN; UNCLASSIFIED DRUG;

ANTIVIRAL THERAPY; CORONAVIRUS; HUMAN; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEASONAL VARIATION; SEROPREVALENCE; SEVERE ACUTE RESPIRATORY SYNDROME; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS PATHOGENESIS;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; CORONAVIRUS; CORONAVIRUS 229E, HUMAN; CORONAVIRUS INFECTIONS; CORONAVIRUS OC43, HUMAN; HUMANS; INFANT; MALE; RESPIRATORY TRACT INFECTIONS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 34547732318     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348:1967-1976.
2. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348:1953-1966.
3. Osterhaus AD, Fouchier RA, Kuiken T. The aetiology of SARS: Koch's postulates fulfilled. Philos Trans R Soc Lond B Biol Sci 2004; 359:1081-1082.
4. Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005; 310:676-679.
5. Lau SK, Woo PC, Li K, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A 2005; 102:14040-14045.
6. Tyrrell DAJ, Bynoe ML. Cultivation of novel type of common-cold virus in organ cultures. Br Med J 1965; 1:1467-1470.
7. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1966; 121:190-193.
8. van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med 2004; 10:368-373.
9. Woo PC, Lau SK, Chu CM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005; 79:884-895.
10. Bradburne AF, Bynoe ML, Tyrrell DA. Effects of a "new" human respiratory virus in volunteers. Br Med J 1967; 3:767-769.
11. Kendall EJ, Bynoe ML, Tyrrell DA. Virus isolations from common colds occurring in a residential school. Br Med J 1962; 5297:82-86.
12. McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A 1967; 57:933-940.
13. Bradburne AF, Somerset BA. Coronative antibody tires in sera of healthy adults and experimentally infected volunteers. J Hyg (Lond) 1972; 70:235-244.
14. McIntosh K, Kapikian AZ, Hardison KA, Hartley JW, Chanock RM. Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J Immunol 1969; 102:1109-1118.
15. Hendley JO, Fishburne HB, Gwaltney JM Jr. Coronavirus infections in working adults. Eight-year study with 229E and OC43. Am Rev Respir Dis 1972; 105:805-811.
16. McIntosh K, Chao RK, Krause HE, Wasil R, Mocega HE, Mufson MA. Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis 1974; 130:502-507.
17. Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 1997; 315:1060-1064.
18. van Elden LJ, van Loon AM, van Alphen F, et al. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis 2004; 189:652-657.
19. Gerna G, Passarani N, Battaglia M, Revello MG, Torre D, Cereda PM. Coronaviruses and gastroenteritis: evidence of antigenic relatedness between human enteric coronavirus strains and human coronavirus OC43. Microbiologica 1984; 7:315-322.
20. Fazakerley JK, Buchmeier MJ. Pathogenesis of virus-induced demyelination. Adv Virus Res 1993; 42:249-324.
21. Burks JS, DeVald BL, Jankovsky LD, Gerdes JC. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science 1980; 209:933-934.
22. Murray RS, Brown B, Brian D, Cabirac GF. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol 1992; 31:525-533.
23. Dessau RB, Lisby G, Frederiksen JL. Coronaviruses in brain tissue from patients with multiple sclerosis. Acta Neuropathol (Berl) 2001; 101:601-604.
24. Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol 2000; 74:8913-8921.
25. Fouchier RA, Hartwig NG, Bestebroer TM, et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A 2004; 101:6212-6216.
26. Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 2005; 191:492-498.
27. van der Hoek L, Berkhout B. Questions concerning the New Haven coronavirus. J Infect Dis 2005; 192:350-351.
28. Lambert S, Mackay IM, Sloots TP, Nissen MD. Human coronavirus nomenclature. Pediatr Infect Dis J 2006; 25:662.
29. Arden KE, Nissen MD, Sloots TP, Mackay IM. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol 2005; 75:455-462.
30. Chiu SS, Chan KH, Chu, KW, et al. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis 2005; 40:1721-1729.
31. Bastien N, Anderson K, Hart L, et al. Human coronavirus NL63 infection in Canada. J Infect Dis 2005; 191:503-506.
32. Ebihara T, Endo R, Ma X, Ishiguro N, Kikuta H. Detection of human coronavirus NL63 in young children with bronchiolitis. J Med Virol 2005; 75:463-465.
33. Moes E, Vijgen L, Keyaerts E, et al. A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis 2005; 5:6.
34. Vabret A, Mourez T, Dina J, et al. Human coronavirus NL63, France. Emerg Infect Dis 2005; 11:1225-1229.
35. Kaiser L, Regamey N, Roiha H, Deffernez C, Frey U. Human coronavirus NL63 associated with lower respiratory tract symptoms in early life. Pediatr Infect Dis J 2005; 24:1015-1017.
36. Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD, Mackay IM. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol 2006; 35:99-102.
37. Vabret A, Dina J, Gouarin S, Petitjean J, Corbet S, Freymuth F. Detection of the new human coronavirus HKU1: a report of 6 cases. Clin Infect Dis 2006; 42:634-639.
38. Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Coronavirus HKU1 infection in the United States. Emerg Infect Dis 2006; 12:775-779.
39. Choi EH, Lee HJ, Kim SJ, et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect Dis 2006; 43:585-592.
40. Gerna G, Campanini G, Rovida F, et al. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol 2006; 78:938-949.
41. Garbino J, Crespo S, Aubert JD, et al. A prospective hospital-based study of the cfinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection. Clin Infect Dis 2006; 43:1009-1015.
42. Koetz A, Nilsson P, Linden M, van der Hoek L, Ripa T. Detection of human coronavirus NL63, human metapneumovirus and respiratory syncytial virus in children with respiratory tract infections in south-west Sweden. Clin Microbiol Infect 2006; 12:1089-1096.
43. Bastien N, Robinson JL, Tse A, Lee BE, Hart L, Li Y. Human coronavirus NL-63 infections in children: a 1-year study. J Clin Microbiol 2005; 43:4567-4573.
44. van der Hoek L, Sure K, Ihorst G, et al. Croup is associated with the novel coronavirus NL63. PLoS Med 2005; 2:e240.
45. Hayden FG. Respiratory viral threats. Curr Opin Infect Dis 2006; 19:169-178.
46. Woo PC, Lau SK, Tsoi HW, et al. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis 2005; 192:1898-1907.
47. Lau SK, Woo PC, Yip CC, et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 2006; 44:2063-2071.
48. Denny FW, Murphy TF, Clyde WA Jr, Collier AM, Henderson FW. Croup: an 11-year study in a pediatric practice. Pediatrics 1983; 71:871-876.
49. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki Disease. J Infect Dis 2005; 191:499-502.
50. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364:533-544.
51. Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis 2005; 9:185-194.
52. Ebihara T, Endo R, Ma X, Ishiguro N, Kikuta H. Lack of association between New Haven coronavirus and Kawasaki disease. J Infect Dis 2005; 192:351-352.
53. Belay ED, Erdman DD, Anderson LJ, et al. Kawasaki disease and human coronavirus. J Infect Dis 2005; 192:352-353.
54. Shimizu C, Shike H, Baker SC, et al. Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki Disease. J Infect Dis 2005; 192:1767-1771.
55. Chang LY, Chiang BL, Kao CL, et al. Lack of association between Infection with a Novel Human Coronavirus (HCoV), HCoV-NH, and Kawasaki Disease in Taiwan. J Infect Dis 2006; 193:283-286.
56. Boivin G, Baz M, Cote S, et al. Infections by human coronavirus-NL in hospitalized children. Pediatr Infect Dis J 2005; 24:1045-1048.
57. Bulut Y, Guven M, Otlu B, et al. Acute otitis media and respiratory viruses. Eur J Pediatr 2007; 166:223-228.
58. McIntosh K (1996). Coronaviruses. In Fields Virology, 3rd edn; pp. 1095-1103 Edited by BN Fields, DM Knipe, PM Howley, et al. Philadelphia: Lippincott-Raven Publishers.
59. Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pohlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A 2005; 102:7988-7993.
60. Woo PC, Lau SK, Yip CC, et al. Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. J Virol 2006; 80:7136-7145.
61. Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003; 77:8801-8811.
62. Bosch BJ, Martina BE, van der Zee R, et al. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A 2004; 101:8455-8460.
63. Pyrc K, Bosch BJ, Berkhout B, et al. Inhibition of HCoV-NL63 infection at early stages of the replication cycle. Antimicrob Agents Chemoth 2006; 50:2000-2008.
64. Haasnoot PCJ, Cupac D, Berkhout B. Inhibition of virus replication by RNA interference. J Biomed Sc 2003; 10:607-616.
65. Bitko V, Musiyenko A, Shulyayeva O, Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 2005; 11:50-55.
66. Li BJ, Tang Q, Cheng D, et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 2005; 11:944-951.
67. Zhang W, Yang H, Kong X, et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 2005; 11:56-62.
68. Stockman LJ, Bellamy R, Garner P. SARS: Systematic Review of Treatment Effects. PLoS Med 2006; 3:e343.
69. Hertzig T, Scandella E, Schelle B, et al. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. J Gen Virol 2004; 85:1717-1725.
70. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet 2003; 362:293-294.
71. Stroher U, DiCaro A, Li Y, et al. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-α. J Infect Dis 2004; 189:1164-1167.
72. Tan EL, Ooi EE, Lin CY, et al. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis 2004; 10:581-586.
73. Haagmans BL, Kuiken T, Martina BE, et al. Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 2004; 10:290-293.
74. Tyrrell DA. The efficacy and tolerance of intranasal interferons: studies at the Common Cold Unit. J Antimicrob Chemother 1986; 18 Suppl B:153-156.
75. Jefferson TO, Tyrrell D. Antivirals for the common cold. Cochrane Database Syst Rev 2001; CD002743.
76. Hemming VG, Rodriguez W, Kim HW, et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 1987; 31:1882-1886.
77. Stiehm ER, Ashida E, Kim KS, Winston DJ, Haas A, Gale RP. Intravenous immunoglobulins as therapeutic agents. Ann Intern Med 1987; 107:367-382.
78. Yang H, Xie W, Xue X, et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol 2005; 3:e324.
79. Blanchard JE, Elowe NH, Huitema C, et al. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chem Biol 2004; 11:1445-1453.
80. Suzuki A, Okamoto M, Ohmi A, Watanabe O, Miyabayashi S, Nishimura H. Detection of human coronavirus-NL63 in children in Japan. Pediatr Infect Dis J 2005; 24:645-646.